C. Gregory Peters
Stock Analyst at Raymond James
(4.78)
# 90
Out of 4,834 analysts
203
Total ratings
73.94%
Success rate
14.46%
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EG Everest Group | Reiterates: Strong Buy | $420 → $410 | $341.48 | +20.07% | 2 | May 6, 2025 | |
| ALL The Allstate Corporation | Reiterates: Strong Buy | $240 → $250 | $203.51 | +22.84% | 24 | May 5, 2025 | |
| HIG The Hartford Insurance Group | Maintains: Outperform | $125 → $135 | $128.26 | +5.25% | 7 | Mar 31, 2025 | |
| HQY HealthEquity | Upgrades: Strong Buy | $120 → $115 | $97.89 | +17.48% | 12 | Mar 25, 2025 | |
| MCY Mercury General | Upgrades: Strong Buy | $70 → $80 | $61.96 | +29.13% | 6 | Feb 12, 2025 | |
| MMC Marsh & McLennan Companies | Reiterates: Outperform | $240 → $250 | $225.65 | +10.79% | 17 | Feb 6, 2025 | |
| KMPR Kemper | Maintains: Strong Buy | $75 → $82 | $64.29 | +27.56% | 13 | Dec 26, 2024 | |
| HGTY Hagerty | Downgrades: Underperform | n/a | $9.70 | - | 2 | Dec 26, 2024 | |
| PGR The Progressive Corporation | Upgrades: Outperform | $305 | $279.45 | +9.14% | 20 | Dec 26, 2024 | |
| WTW Willis Towers Watson | Upgrades: Strong Buy | $365 → $400 | $307.72 | +29.99% | 10 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $11.06 | +44.67% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $45 → $55 | $62.25 | -11.65% | 8 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $110 | $110.10 | -0.09% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $40 → $45 | $38.95 | +15.53% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $270 → $285 | $289.51 | -1.56% | 8 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $220 → $245 | $268.74 | -8.83% | 7 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $335.71 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $306.10 | -15.06% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $37.72 | -20.47% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $356.75 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $148.08 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $74.39 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $105.18 | -36.30% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.33 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $42.00 | - | 1 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.43 | - | 4 | Feb 1, 2021 |
Everest Group
May 6, 2025
Reiterates: Strong Buy
Price Target: $420 → $410
Current: $341.48
Upside: +20.07%
The Allstate Corporation
May 5, 2025
Reiterates: Strong Buy
Price Target: $240 → $250
Current: $203.51
Upside: +22.84%
The Hartford Insurance Group
Mar 31, 2025
Maintains: Outperform
Price Target: $125 → $135
Current: $128.26
Upside: +5.25%
HealthEquity
Mar 25, 2025
Upgrades: Strong Buy
Price Target: $120 → $115
Current: $97.89
Upside: +17.48%
Mercury General
Feb 12, 2025
Upgrades: Strong Buy
Price Target: $70 → $80
Current: $61.96
Upside: +29.13%
Marsh & McLennan Companies
Feb 6, 2025
Reiterates: Outperform
Price Target: $240 → $250
Current: $225.65
Upside: +10.79%
Kemper
Dec 26, 2024
Maintains: Strong Buy
Price Target: $75 → $82
Current: $64.29
Upside: +27.56%
Hagerty
Dec 26, 2024
Downgrades: Underperform
Price Target: n/a
Current: $9.70
Upside: -
The Progressive Corporation
Dec 26, 2024
Upgrades: Outperform
Price Target: $305
Current: $279.45
Upside: +9.14%
Willis Towers Watson
Dec 5, 2024
Upgrades: Strong Buy
Price Target: $365 → $400
Current: $307.72
Upside: +29.99%
Nov 12, 2024
Maintains: Outperform
Price Target: $15 → $16
Current: $11.06
Upside: +44.67%
Nov 5, 2024
Maintains: Strong Buy
Price Target: $45 → $55
Current: $62.25
Upside: -11.65%
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $110.10
Upside: -0.09%
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $38.95
Upside: +15.53%
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $289.51
Upside: -1.56%
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $268.74
Upside: -8.83%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $335.71
Upside: -
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $306.10
Upside: -15.06%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $37.72
Upside: -20.47%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $356.75
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $148.08
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $74.39
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $105.18
Upside: -36.30%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $7.33
Upside: -
Feb 19, 2021
Initiates: Market Perform
Price Target: n/a
Current: $42.00
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.43
Upside: -